**Core Concept**
The concept of extended drug resistance in tuberculosis (TB) refers to the development of resistance to multiple first-line and second-line anti-tubercular drugs, making treatment challenging. The management of extended drug-resistant TB requires the use of second-line anti-tubercular drugs, which have different mechanisms of action and resistance patterns.

**Why the Correct Answer is Right**
The correct answer is a combination of drugs that are not typically used for the treatment of extended drug-resistant TB. The management of extended drug-resistant TB involves the use of a combination of drugs, including aminoglycosides (e.g., kanamycin, amikacin), polypeptides (e.g., capreomycin), and fluoroquinolones (e.g., moxifloxacin). These drugs are effective against TB bacteria that are resistant to first-line drugs.

**Why Each Wrong Option is Incorrect**
**Option A:** is a correct choice for extended drug-resistant TB, as it includes a fluoroquinolone and a second-line injectable agent.
**Option B:** is also a correct choice, as it includes a combination of a fluoroquinolone and a second-line injectable agent.
**Option D:** is a correct choice, as it includes a combination of a fluoroquinolone and a second-line injectable agent.

**Clinical Pearl / High-Yield Fact**
When managing extended drug-resistant TB, it's essential to consider the patient's previous treatment history, the site of disease, and the presence of any resistance patterns. A thorough diagnostic workup, including culture and drug susceptibility testing, is crucial to guide treatment decisions.

**Correct Answer:** C.